Has Esther Schlesinger received payments from drug or device companies?

Yes. Drug and device makers reported $7,225 in general payments to Esther Schlesinger across 228 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Esther Schlesinger did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Esther Schlesinger come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Esther Schlesinger

Psychiatry · Clark, NJNPI 1447341722

Payments from drug & device makers

$7,225in general payments, 2019–2025

Across 228 payments — averaging $31.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$1K
Neurocrine Biosciences, Inc.$1K
Otsuka America Pharmaceutical, Inc.$1K
Teva Pharmaceuticals USA, Inc.$994
AbbVie$789
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$464
plus $700 from 7 others

What the payments were for

Food & beverage$7,222100%
Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	42	$1,487
Neurocrine Biosciences, Inc.	18	$1,402
Otsuka America Pharmaceutical, Inc.	41	$1,388
Teva Pharmaceuticals USA, Inc.	32	$994
AbbVie(2 entities)	62	$789
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$464
Alkermes, Inc.	4	$286
Axsome Therapeutics, Inc.	1	$122
Sunovion Pharmaceuticals Inc.	4	$112
Indivior Inc.	6	$83
E.r. Squibb & Sons, L.L.C.	1	$55
Takeda Pharmaceuticals U.S.A., Inc.	2	$27
Noven Therapeutics, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,225 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	20	$58,582
Olanzapine OdtOlanzapine	39	$5,801
Olanzapine	78	$4,333
Paroxetine ErParoxetine Hcl	31	$2,221
Fluphenazine Decanoate	19	$2,173
Fluphenazine Hcl	20	$1,951
Oxcarbazepine	15	$1,347
Aripiprazole	51	$1,215
Paliperidone ErPaliperidone	11	$1,072
Haloperidol	35	$795
Haloperidol Decanoate	19	$783
Clozapine	19	$758
Risperidone	42	$744
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	18	$469
Benztropine Mesylate	38	$350

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna	$1,487	$58,58220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Clark

Leon RosenbergCherry Hill$6.4M
Steven GlassClementon$3.9M
Judith JosephPaterson$3.8M
Jeffrey ApterPrinceton$1.7M
Roberta BallCherry Hill$741K
Marc CantillonLivingston$524K
Sanjay VarmaPrinceton$479K
Manuel SanchezNewark$474K
Robert BransfieldRed Bank$415K
Erika ConcepcionLong Branch$354K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →